SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 103 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $234,000 | -8.9% | 243,068 | +12.2% | 0.00% | – |
| Q1 2022 | $257,000 | -84.1% | 216,602 | -56.2% | 0.00% | – |
| Q4 2021 | $1,614,000 | -26.4% | 494,894 | +0.9% | 0.00% | – |
| Q3 2021 | $2,192,000 | -19.8% | 490,501 | -2.1% | 0.00% | -100.0% |
| Q2 2021 | $2,732,000 | -42.7% | 501,221 | -21.3% | 0.00% | 0.0% |
| Q1 2021 | $4,764,000 | +272.5% | 636,920 | +440.3% | 0.00% | – |
| Q4 2020 | $1,279,000 | +57.1% | 117,882 | +28.0% | 0.00% | – |
| Q3 2020 | $814,000 | +21.5% | 92,068 | +46.4% | 0.00% | – |
| Q2 2020 | $670,000 | +146.3% | 62,870 | +36.9% | 0.00% | – |
| Q1 2020 | $272,000 | -23.8% | 45,934 | -11.0% | 0.00% | – |
| Q4 2019 | $357,000 | -5.6% | 51,598 | +41.6% | 0.00% | – |
| Q3 2019 | $378,000 | +118.5% | 36,447 | +95.1% | 0.00% | – |
| Q2 2019 | $173,000 | -21.4% | 18,685 | -22.4% | 0.00% | – |
| Q1 2019 | $220,000 | +66.7% | 24,079 | +1.5% | 0.00% | – |
| Q4 2018 | $132,000 | -12.6% | 23,713 | +86.6% | 0.00% | – |
| Q3 2018 | $151,000 | -77.2% | 12,705 | -80.4% | 0.00% | – |
| Q2 2018 | $661,000 | +293.5% | 64,738 | +401.5% | 0.00% | – |
| Q1 2018 | $168,000 | -1.2% | 12,909 | -7.5% | 0.00% | – |
| Q4 2016 | $170,000 | -58.4% | 13,959 | -52.6% | 0.00% | – |
| Q3 2016 | $409,000 | +12.7% | 29,457 | +47.3% | 0.00% | – |
| Q2 2016 | $363,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 3,139,895 | $23,486,000 | 4.50% |
| Samsara BioCapital, LLC | 2,189,199 | $14,769,000 | 2.72% |
| Bain Capital Life Sciences Investors, LLC | 5,785,036 | $43,272,000 | 2.45% |
| Omega Fund Management, LLC | 1,562,500 | $11,688,000 | 1.11% |
| Flagship Pioneering Inc. | 2,938,494 | $21,980,000 | 0.35% |
| EcoR1 Capital, LLC | 1,000,000 | $7,480,000 | 0.33% |
| Altium Capital Management LP | 126,702 | $948,000 | 0.26% |
| Nikko Asset Management Americas, Inc. | 5,042,009 | $37,714,000 | 0.18% |
| Artal Group S.A. | 1,025,000 | $7,667,000 | 0.14% |
| Orbimed Advisors | 1,837,500 | $13,745,000 | 0.13% |